JOHN WHITE: Open Payments
NPI 1558389833 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 22 payments from 9 companies in 2025. Trend: 2023 $621 · 2024 $317 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $163 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $111 |
| GENZYME CORPORATION | 4 | $80 |
| ABBVIE INC. | 3 | $52 |
| Olympus America Inc. | 1 | $34 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Novo Nordisk Inc | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
Products named: REZDIFFRA, ENTYVIO, DUPIXENT, RINVOQ, EVIS EXERA III VIDEO SYSTEM CENTER, IQIRVO, Wegovy, TREMFYA.
Industry payments across LA — which companies pay providers there.
